PRC/PRMS reviews are conducted by three committees. Committees A and B alternate review of therapeutic oncology trials so that one of the committees meets every two weeks to ensure rapid review of studies and facilitate prompt progression of cancer protocols from the PRC/PRMS to the responsible IRB. Committee C reviews behavioral, cancer epidemiology, cancer control, cancer prevention, and complementary medicine protocols on an ad hoc basis, as needed.
COMMITTEE A | Specialty |
---|---|
Andrew Laman, MD (Chair) | Medical Oncology (Community Physician) |
Yana Najjar, MD (Vice-Chair) | Hematology/Oncology |
Yoshio Arai, MD | Radiation Oncology |
Marija Balic, MD | Hematology/Oncology/Breast |
Parul Barry, MD | Radiation Oncology |
Jennifer (Elyse) Krupp, MPH, CCRC | Quality, education & compliance (CRS) |
Urvashi Joshi, MD | Fellow, Hematology/Oncology |
Jason Luke, MD | Immunotherapeutics/Hematology/Oncology |
Megan Mantica, MD | Neuro-Oncology |
Steven Moretti, PharmD / L. Morelli | Pharmacist |
Geoffrey Nunns, MD | Surgical Oncology |
Adam Olson, MD | Radiation Oncology |
Radhakrishnan Ramchandren, MD | Hematology/Oncology |
Shannon Rush, MD | Gynecologic Oncology |
Alaa Sada, MD | Fellow, Surgical Oncology |
Kainat Saleem, MD | Fellow, Hematology Oncology |
Laura Stabile, PhD | Pharmacology & Chemical Biology |
Hong Wang, PhD / M. Jelinek | Statistician |
COMMITTEE B | Specialty |
---|---|
Leonard Appleman, MD, PhD (Chair) | Hematology/Oncology |
Udai Kammula, MD (Vice-Chair) | Surgical Oncology |
Anne Blake, RPh | Pharmacist |
Andrew Bukowinski, MD | Phase I/COG, CHP |
Melissa Burgess, MD | Hematology/Oncology |
Priyanka Chablani, MD | Hematology/Oncology |
Kristine Cooper, PhD / Shuaichao Wang | Statistician |
Diwakar Davar, MD | Hematology/Oncology |
Jingxiao Jin, MD | Hematology/Oncology |
Zahra Kelly, DO | Fellow, Hematology/Oncology |
Jodi Maranchie, MD | Urology |
Brieana Marino, MA | Regulatory Manager (CRS) |
Alessandro Paniccia, MD | Surgical Oncology |
Khavaramze Shaverdashvili, MD | Hematology/Oncology |
Liza Villaruz, MD | Hematology/Oncology |
Christopher Wilke, MD | Radiation Oncology |
Janie Zhang, MD | Hematology/Oncology |
COMMITTEE C | Specialty |
---|---|
Kathryn Schmitz, PhD, MPH (Chair) | Hematology/Oncology |
Jian-Min Yuan, MD, PhD (Vice-Chair) | Cancer Epidemiology & Prevention Control |
Dana Bovbjerg, PhD | Biobehavioral Cancer Control Program |
Donna Posluszny, PhD | Behavioral Medicine Clinical Service |
Susan Sereika, PhD | Biostatistician |
Alternates (A/B) | Specialty |
---|---|
Tullia Bruno, MD | Immunology/Immunotherapy |
Serah Choi, MD, PhD | PRadiation Oncology |
Julia Foldi, MD, PhD | Hematology/Oncology |
Jeffrey Goff | Pharmacy |
Benjamin Nacev, MD | Hematology/Oncology |
Robert Redner, MD | Hematology/Oncology |
Margaret Rosenzweig, PhD | Oncology, Acute Care Nurse Practitioner Program (Pitt) |